Biotechnology
The Biotechnology industry has a total of 611 stocks, with a combined market cap of $1.07 trillion and total revenue of $105.52 billion.
Market Cap
1.07T
Revenue
105.52B
Profits
-42.88B
PE Ratio
n/a
Profit Margin
-40.63%
Dividend Yield
0.04%
611 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 108.28B | 1.05% | 1,916,828 | 11.72B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 77.55B | 2.56% | 1,427,562 | 14.25B |
| 3 | ALNY | Alnylam Pharmaceuticals, Inc. | 57.65B | -2.11% | 1,297,695 | 3.21B |
| 4 | ARGX | argenx SE | 56.33B | 0.05% | 328,114 | 3.68B |
| 5 | INSM | Insmed Incorporated | 42.39B | -0.44% | 2,629,292 | 447.02M |
| 6 | ONC | BeOne Medicines AG | 38.48B | -0.45% | 163,398 | 5.00B |
| 7 | BNTX | BioNTech SE | 22.99B | -1.42% | 1,314,322 | 3.70B |
| 8 | RPRX | Royalty Pharma plc | 22.47B | 1.38% | 2,878,616 | 2.35B |
| 9 | INCY | Incyte Corporation | 20.04B | 0.29% | 1,703,106 | 4.81B |
| 10 | GMAB | Genmab A/S | 18.66B | 1.36% | 1,035,314 | 3.85B |
| 11 | ROIV | Roivant Sciences Ltd. | 14.06B | -0.25% | 4,204,606 | 20.33M |
| 12 | RVMD | Revolution Medicines, Inc. | 13.70B | 1.42% | 1,939,421 | - |
| 13 | BBIO | BridgeBio Pharma, Inc. | 13.13B | 5.40% | 4,127,267 | 353.78M |
| 14 | ASND | Ascendis Pharma A/S | 12.86B | 0.45% | 594,270 | 758.59M |
| 15 | SMMT | Summit Therapeutics Inc. | 12.48B | -1.58% | 2,763,795 | - |
| 16 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.44B | 1.08% | 567,137 | 740.64M |
| 17 | IONS | Ionis Pharmaceuticals, Inc. | 12.32B | 4.06% | 2,075,779 | 966.96M |
| 18 | EXEL | Exelixis, Inc. | 11.44B | 1.75% | 2,810,852 | 2.29B |
| 19 | JAZZ | Jazz Pharmaceuticals plc | 10.75B | 0.68% | 1,016,812 | 4.16B |
| 20 | RNA | Avidity Biosciences, Inc. | 10.63B | -0.13% | 3,080,464 | 20.87M |
| 21 | BMRN | BioMarin Pharmaceutical Inc. | 10.51B | 4.21% | 3,002,455 | 3.09B |
| 22 | TECH | Bio-Techne Corporation | 9.59B | 4.77% | 1,960,761 | 1.22B |
| 23 | MRNA | Moderna, Inc. | 9.27B | 6.08% | 13,902,055 | 2.23B |
| 24 | ABVX | ABIVAX Société Anonyme | 8.92B | -3.08% | 1,700,173 | 7.07M |
| 25 | HALO | Halozyme Therapeutics, Inc. | 8.27B | 1.99% | 2,194,388 | 1.24B |
| 26 | CORT | Corcept Therapeutics Incorporated | 8.13B | 2.98% | 542,859 | 741.17M |
| 27 | CYTK | Cytokinetics, Incorporated | 8.00B | 3.06% | 1,410,427 | 87.21M |
| 28 | NUVL | Nuvalent, Inc. | 7.70B | -1.97% | 1,218,748 | - |
| 29 | AXSM | Axsome Therapeutics, Inc. | 7.53B | 4.28% | 531,375 | 561.26M |
| 30 | MRUS | Merus N.V. | 7.26B | -0.23% | 1,686,675 | 56.61M |
| 31 | CDTX | Cidara Therapeutics, Inc. | 6.90B | -0.09% | 1,248,100 | 302.00K |
| 32 | CAI | Caris Life Sciences, Inc. | 6.80B | 0.25% | 1,530,707 | 649.06M |
| 33 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.79B | 1.07% | 467,714 | 174.33M |
| 34 | PTCT | PTC Therapeutics, Inc. | 6.30B | 2.63% | 1,322,198 | 1.78B |
| 35 | PCVX | Vaxcyte, Inc. | 6.25B | 0.23% | 1,791,788 | - |
| 36 | KRYS | Krystal Biotech, Inc. | 6.15B | 3.81% | 320,522 | 373.16M |
| 37 | ARWR | Arrowhead Pharmaceuticals, Inc. | 5.59B | 6.20% | 3,506,837 | 572.98M |
| 38 | COGT | Cogent Biosciences, Inc. | 5.59B | 5.94% | 3,312,389 | - |
| 39 | PTGX | Protagonist Therapeutics, Inc. | 5.34B | 1.43% | 906,112 | 209.22M |
| 40 | ACLX | Arcellx, Inc. | 5.22B | 0.69% | 503,976 | 35.90M |
| 41 | LEGN | Legend Biotech Corporation | 5.20B | 2.32% | 2,055,022 | 909.05M |
| 42 | CRSP | CRISPR Therapeutics AG | 4.79B | 1.91% | 2,753,292 | 38.34M |
| 43 | KYMR | Kymera Therapeutics, Inc. | 4.75B | 2.18% | 768,939 | 43.74M |
| 44 | TGTX | TG Therapeutics, Inc. | 4.67B | 4.93% | 2,685,942 | 531.90M |
| 45 | CELC | Celcuity Inc. | 4.51B | 3.72% | 1,291,979 | - |
| 46 | APGE | Apogee Therapeutics, Inc. | 4.47B | 4.56% | 625,465 | - |
| 47 | AKRO | Akero Therapeutics, Inc. | 4.47B | 0.15% | 1,123,013 | - |
| 48 | NAMS | NewAmsterdam Pharma Company N.V. | 4.34B | 1.49% | 1,461,278 | 35.24M |
| 49 | PRAX | Praxis Precision Medicines, Inc. | 4.25B | 3.48% | 1,477,382 | 7.46M |
| 50 | BLTE | Belite Bio, Inc | 4.21B | 10.42% | 363,879 | - |
| 51 | SRRK | Scholar Rock Holding Corporation | 4.10B | 5.76% | 2,076,655 | - |
| 52 | ADMA | ADMA Biologics, Inc. | 4.09B | 5.01% | 4,307,217 | 488.56M |
| 53 | CNTA | Centessa Pharmaceuticals plc | 4.09B | 1.60% | 1,622,950 | 15.00M |
| 54 | CRNX | Crinetics Pharmaceuticals, Inc. | 4.07B | 2.07% | 889,286 | 1.54M |
| 55 | ACAD | ACADIA Pharmaceuticals Inc. | 3.99B | 2.88% | 1,353,636 | 1.05B |
| 56 | IMVT | Immunovant, Inc. | 3.96B | -0.88% | 1,885,674 | - |
| 57 | VKTX | Viking Therapeutics, Inc. | 3.87B | -0.03% | 2,851,663 | - |
| 58 | MIRM | Mirum Pharmaceuticals, Inc. | 3.65B | 2.57% | 720,991 | 471.79M |
| 59 | ARQT | Arcutis Biotherapeutics, Inc. | 3.61B | 7.90% | 2,594,315 | 317.93M |
| 60 | IRON | Disc Medicine, Inc. | 3.50B | 2.49% | 853,492 | - |
| 61 | CGON | CG Oncology, Inc. | 3.42B | 4.25% | 708,335 | 2.17M |
| 62 | TARS | Tarsus Pharmaceuticals, Inc. | 3.38B | 3.48% | 428,468 | 366.10M |
| 63 | MLYS | Mineralys Therapeutics, Inc. | 3.31B | - | 1,675,598 | - |
| 64 | RARE | Ultragenyx Pharmaceutical Inc. | 3.23B | 7.73% | 1,682,763 | 630.60M |
| 65 | XENE | Xenon Pharmaceuticals Inc. | 3.18B | 2.21% | 625,942 | 7.50M |
| 66 | TVTX | Travere Therapeutics, Inc. | 3.10B | -0.12% | 1,622,505 | 435.83M |
| 67 | DYN | Dyne Therapeutics, Inc. | 3.03B | 5.27% | 1,907,873 | - |
| 68 | TLX | Telix Pharmaceuticals Limited | 3.00B | 1.60% | 155,883 | 664.23M |
| 69 | IDYA | IDEAYA Biosciences, Inc. | 2.98B | 2.50% | 587,252 | 214.83M |
| 70 | FOLD | Amicus Therapeutics, Inc. | 2.95B | 1.16% | 3,677,879 | 598.70M |
| 71 | VRDN | Viridian Therapeutics, Inc. | 2.90B | 2.95% | 2,058,466 | 70.79M |
| 72 | CPRX | Catalyst Pharmaceuticals, Inc. | 2.86B | 2.24% | 1,382,908 | 578.20M |
| 73 | AAPG | Ascentage Pharma Group International | 2.86B | -2.05% | 1,370 | 54.52M |
| 74 | ADPT | Adaptive Biotechnologies Corporation | 2.84B | 14.03% | 5,067,897 | 252.75M |
| 75 | DNLI | Denali Therapeutics Inc. | 2.64B | 4.90% | 1,449,649 | - |
| 76 | OCUL | Ocular Therapeutix, Inc. | 2.61B | 4.44% | 3,276,934 | 55.78M |
| 77 | LQDA | Liquidia Corporation | 2.53B | 1.93% | 2,173,492 | 69.22M |
| 78 | APLS | Apellis Pharmaceuticals, Inc. | 2.48B | 0.36% | 1,452,236 | 1.02B |
| 79 | SLNO | Soleno Therapeutics, Inc. | 2.42B | 0.36% | 1,309,577 | 98.68M |
| 80 | EWTX | Edgewise Therapeutics, Inc. | 2.40B | 1.89% | 1,283,036 | - |
| 81 | NUVB | Nuvation Bio Inc. | 2.40B | -0.29% | 11,224,287 | 26.75M |
| 82 | RCUS | Arcus Biosciences, Inc. | 2.38B | 3.86% | 2,031,437 | 240.00M |
| 83 | TERN | Terns Pharmaceuticals, Inc. | 2.37B | 0.79% | 2,486,486 | - |
| 84 | ZLAB | Zai Lab Limited | 2.21B | -0.94% | 631,519 | 441.63M |
| 85 | BEAM | Beam Therapeutics Inc. | 2.19B | 7.82% | 1,945,820 | 55.70M |
| 86 | RXRX | Recursion Pharmaceuticals, Inc. | 2.17B | 8.31% | 33,598,945 | 43.69M |
| 87 | GPCR | Structure Therapeutics Inc. | 2.08B | -0.06% | 819,523 | - |
| 88 | AUPH | Aurinia Pharmaceuticals Inc. | 2.07B | 3.57% | 1,789,139 | 265.81M |
| 89 | IBRX | ImmunityBio, Inc. | 2.05B | 2.97% | 9,942,049 | 82.56M |
| 90 | GLPG | Galapagos NV | 2.01B | 1.55% | 87,856 | 336.64M |
| 91 | VCEL | Vericel Corporation | 2.00B | 4.46% | 701,545 | 258.72M |
| 92 | IMCR | Immunocore Holdings plc | 1.99B | 0.87% | 404,276 | 379.59M |
| 93 | HRMY | Harmony Biosciences Holdings, Inc. | 1.98B | 2.76% | 777,651 | 825.94M |
| 94 | SION | Sionna Therapeutics, Inc. | 1.95B | 12.12% | 270,145 | - |
| 95 | ZBIO | Zenas BioPharma, Inc. | 1.92B | 2.76% | 240,113 | 15.00M |
| 96 | MESO | Mesoblast Limited | 1.91B | 7.33% | 200,855 | 17.20M |
| 97 | SYRE | Spyre Therapeutics, Inc. | 1.88B | 3.37% | 496,266 | - |
| 98 | SRPT | Sarepta Therapeutics, Inc. | 1.85B | 7.34% | 3,939,168 | 2.41B |
| 99 | VERA | Vera Therapeutics, Inc. | 1.82B | 2.12% | 789,277 | - |
| 100 | ZYME | Zymeworks Inc. | 1.80B | 0.84% | 1,688,183 | 134.48M |
| 101 | DNTH | Dianthus Therapeutics, Inc. | 1.78B | 2.62% | 834,775 | 3.08M |
| 102 | MAZE | Maze Therapeutics, Inc. | 1.74B | 1.94% | 398,206 | 2.50M |
| 103 | QURE | uniQure N.V. | 1.73B | -0.32% | 2,108,994 | 15.75M |
| 104 | JANX | Janux Therapeutics, Inc. | 1.73B | 0.73% | 796,050 | 10.00M |
| 105 | CLDX | Celldex Therapeutics, Inc. | 1.72B | 3.39% | 607,625 | 2.60M |
| 106 | IMNM | Immunome, Inc. | 1.70B | 5.83% | 1,430,046 | 9.68M |
| 107 | NRIX | Nurix Therapeutics, Inc. | 1.70B | 9.33% | 2,330,840 | 83.69M |
| 108 | STOK | Stoke Therapeutics, Inc. | 1.68B | 5.05% | 1,083,096 | 205.63M |
| 109 | PHVS | Pharvaris N.V. | 1.61B | 2.60% | 475,030 | - |
| 110 | AMLX | Amylyx Pharmaceuticals, Inc. | 1.61B | 8.11% | 1,303,564 | -665.00K |
| 111 | OLMA | Olema Pharmaceuticals, Inc. | 1.59B | 5.27% | 5,189,909 | - |
| 112 | INVA | Innoviva, Inc. | 1.57B | -0.95% | 797,551 | 388.52M |
| 113 | MNKD | MannKind Corporation | 1.54B | 1.21% | 2,669,268 | 313.79M |
| 114 | SNDX | Syndax Pharmaceuticals, Inc. | 1.52B | 2.29% | 1,872,437 | 111.30M |
| 115 | AGIO | Agios Pharmaceuticals, Inc. | 1.47B | 2.73% | 3,635,858 | 44.79M |
| 116 | ORKA | Oruka Therapeutics, Inc. | 1.42B | 8.52% | 397,323 | - |
| 117 | TRVI | Trevi Therapeutics, Inc. | 1.41B | 3.19% | 1,235,612 | - |
| 118 | UPB | Upstream Bio, Inc. | 1.38B | 2.36% | 384,483 | 2.80M |
| 119 | PGEN | Precigen, Inc. | 1.37B | -0.51% | 4,610,645 | 6.31M |
| 120 | TNGX | Tango Therapeutics, Inc. | 1.35B | 12.70% | 4,559,488 | 66.50M |
| 121 | ARDX | Ardelyx, Inc. | 1.32B | -2.34% | 3,607,980 | 398.23M |
| 122 | RAPP | Rapport Therapeutics, Inc. | 1.30B | 1.49% | 468,355 | - |
| 123 | ELVN | Enliven Therapeutics, Inc. | 1.29B | 2.21% | 348,706 | - |
| 124 | BHVN | Biohaven Ltd. | 1.29B | 0.62% | 3,382,631 | - |
| 125 | IMTX | Immatics N.V. | 1.24B | 0.99% | 472,315 | 99.45M |
| 126 | INBX | Inhibrx Biosciences, Inc. | 1.22B | 5.12% | 353,988 | 1.40M |
| 127 | MBX | MBX Biosciences, Inc. | 1.22B | 0.18% | 772,818 | - |
| 128 | URGN | UroGen Pharma Ltd. | 1.21B | 4.15% | 773,570 | 96.52M |
| 129 | SVRA | Savara Inc. | 1.19B | 5.35% | 2,398,286 | - |
| 130 | WVE | Wave Life Sciences Ltd. | 1.18B | 4.29% | 1,828,754 | 109.23M |
| 131 | RLAY | Relay Therapeutics, Inc. | 1.17B | 6.11% | 2,371,033 | 8.36M |
| 132 | TSHA | Taysha Gene Therapies, Inc. | 1.15B | 5.01% | 4,385,991 | 6.31M |
| 133 | SEPN | Septerna, Inc. | 1.14B | 7.53% | 345,398 | 22.05M |
| 134 | XNCR | Xencor, Inc. | 1.13B | 1.86% | 628,049 | 150.13M |
| 135 | XERS | Xeris Biopharma Holdings, Inc. | 1.13B | -0.15% | 1,717,690 | 266.14M |
| 136 | CVAC | CureVac N.V. | 1.13B | -1.76% | 1,377,075 | 599.54M |
| 137 | EYPT | EyePoint Pharmaceuticals, Inc. | 1.13B | 0.29% | 914,889 | 42.34M |
| 138 | ORIC | ORIC Pharmaceuticals, Inc. | 1.13B | 1.22% | 1,395,007 | - |
| 139 | TYRA | Tyra Biosciences, Inc. | 1.13B | 0.57% | 1,801,209 | - |
| 140 | PHAR | Pharming Group N.V. | 1.12B | 0.06% | 15,247 | 362.27M |
| 141 | OCS | Oculis Holding AG | 1.11B | 0.23% | 100,370 | 992.00K |
| 142 | PVLA | Palvella Therapeutics, Inc. | 1.11B | 2.73% | 232,882 | - |
| 143 | NKTR | Nektar Therapeutics | 1.10B | -1.51% | 646,424 | 62.60M |
| 144 | KOD | Kodiak Sciences Inc. | 1.10B | 5.77% | 987,692 | - |
| 145 | ANAB | AnaptysBio, Inc. | 1.10B | 5.18% | 1,525,228 | 169.47M |
| 146 | MNMD | Mind Medicine (MindMed) Inc. | 1.05B | -1.84% | 1,729,364 | - |
| 147 | NVAX | Novavax, Inc. | 1.05B | 4.02% | 4,033,740 | 1.06B |
| 148 | ABCL | AbCellera Biologics Inc. | 1.05B | 2.93% | 3,492,333 | 35.33M |
| 149 | PHAT | Phathom Pharmaceuticals, Inc. | 1.04B | 4.46% | 740,276 | 147.19M |
| 150 | NBTX | Nanobiotix S.A. | 1.01B | 2.70% | 28,055 | 11.93M |
| 151 | FTRE | Fortrea Holdings Inc. | 1.01B | 8.57% | 923,794 | 2.76B |
| 152 | MDXG | MiMedx Group, Inc. | 1.00B | 3.21% | 834,751 | 393.44M |
| 153 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 991.06M | 1.72% | 114,073 | - |
| 154 | BCAX | Bicara Therapeutics Inc. | 988.27M | 11.50% | 778,513 | - |
| 155 | KURA | Kura Oncology, Inc. | 971.99M | 1.73% | 1,148,022 | 104.03M |
| 156 | MRVI | Maravai LifeSciences Holdings, Inc. | 958.90M | 9.65% | 2,720,978 | 192.44M |
| 157 | NTLA | Intellia Therapeutics, Inc. | 950.96M | 2.11% | 6,239,173 | 57.53M |
| 158 | TBPH | Theravance Biopharma, Inc. | 936.43M | 3.24% | 566,874 | 80.33M |
| 159 | GLUE | Monte Rosa Therapeutics, Inc. | 925.97M | 5.18% | 676,797 | 181.54M |
| 160 | LENZ | LENZ Therapeutics, Inc. | 924.93M | 6.64% | 1,008,111 | 17.50M |
| 161 | RZLT | Rezolute, Inc. | 911.51M | 1.87% | 1,341,856 | - |
| 162 | MLTX | MoonLake Immunotherapeutics | 904.30M | -2.54% | 2,310,742 | - |
| 163 | IOVA | Iovance Biotherapeutics, Inc. | 889.21M | 2.75% | 8,080,340 | 250.43M |
| 164 | SANA | Sana Biotechnology, Inc. | 876.34M | 1.86% | 2,984,530 | - |
| 165 | DAWN | Day One Biopharmaceuticals, Inc. | 874.80M | 2.77% | 2,929,664 | 133.67M |
| 166 | GHRS | GH Research PLC | 869.34M | 0.18% | 128,941 | - |
| 167 | CMPX | Compass Therapeutics, Inc. | 866.19M | 0.41% | 2,507,807 | 850.00K |
| 168 | AVBP | ArriVent BioPharma, Inc. | 840.08M | 1.45% | 164,667 | - |
| 169 | RIGL | Rigel Pharmaceuticals, Inc. | 838.86M | 5.42% | 536,541 | 282.08M |
| 170 | ABUS | Arbutus Biopharma Corporation | 828.92M | 2.62% | 800,433 | 14.61M |
| 171 | ERAS | Erasca, Inc. | 828.44M | 5.04% | 1,670,120 | - |
| 172 | ATAI | Atai Beckley N.V. | 814.49M | 3.83% | 3,855,033 | 3.02M |
| 173 | VIR | Vir Biotechnology, Inc. | 790.23M | 2.16% | 967,040 | 16.86M |
| 174 | VSTM | Verastem, Inc. | 771.82M | 1.94% | 2,458,282 | 13.38M |
| 175 | CRMD | CorMedix Inc. | 762.68M | -0.41% | 2,527,076 | 214.30M |
| 176 | ALMS | Alumis Inc. | 762.07M | 5.49% | 2,424,013 | 22.12M |
| 177 | RAPT | RAPT Therapeutics, Inc. | 750.41M | -0.73% | 282,808 | - |
| 178 | SPRY | ARS Pharmaceuticals, Inc. | 750.26M | 12.78% | 3,873,796 | 142.77M |
| 179 | VALN | Valneva SE | 744.11M | 1.88% | 14,800 | 211.09M |
| 180 | ARVN | Arvinas, Inc. | 739.86M | 4.54% | 1,806,241 | 312.30M |
| 181 | REPL | Replimune Group, Inc. | 721.68M | 2.11% | 1,702,508 | - |
| 182 | GERN | Geron Corporation | 714.96M | 1.82% | 7,307,377 | 183.40M |
| 183 | ATXS | Astria Therapeutics, Inc. | 714.13M | 0.48% | 650,991 | 706.00K |
| 184 | GOSS | Gossamer Bio, Inc. | 708.26M | -1.61% | 2,738,701 | 44.05M |
| 185 | GYRE | Gyre Therapeutics, Inc. | 682.59M | 0.27% | 47,506 | 107.27M |
| 186 | VTYX | Ventyx Biosciences, Inc. | 672.91M | -1.87% | 1,828,733 | - |
| 187 | KALV | KalVista Pharmaceuticals, Inc. | 662.16M | 0.46% | 989,234 | 1.43M |
| 188 | LXEO | Lexeo Therapeutics, Inc. | 661.27M | 1.63% | 682,337 | - |
| 189 | PROK | ProKidney Corp. | 658.83M | 4.78% | 1,526,184 | 744.00K |
| 190 | CTMX | CytomX Therapeutics, Inc. | 657.41M | 2.92% | 1,783,803 | 113.63M |
| 191 | PRME | Prime Medicine, Inc. | 642.65M | -1.63% | 2,728,395 | 5.98M |
| 192 | CRVS | Corvus Pharmaceuticals, Inc. | 640.02M | 0.71% | 764,471 | - |
| 193 | OMER | Omeros Corporation | 628.89M | 7.78% | 1,225,957 | - |
| 194 | FDMT | 4D Molecular Therapeutics, Inc. | 619.34M | 4.84% | 559,440 | 120.00K |
| 195 | ANNX | Annexon, Inc. | 617.99M | - | 3,973,519 | - |
| 196 | MNPR | Monopar Therapeutics Inc. | 611.86M | 10.31% | 96,512 | - |
| 197 | FULC | Fulcrum Therapeutics, Inc. | 611.00M | 2.08% | 431,992 | 80.00M |
| 198 | MPLT | MapLight Therapeutics, Inc. | 610.54M | 5.27% | 264,661 | - |
| 199 | ASMB | Assembly Biosciences, Inc. | 608.96M | 4.82% | 223,798 | 37.19M |
| 200 | MGTX | MeiraGTx Holdings plc | 600.46M | 0.40% | 553,484 | 27.42M |
| 201 | RGNX | REGENXBIO Inc. | 597.35M | 8.56% | 453,051 | 161.32M |
| 202 | YDES | YD Bio Limited | 594.20M | 1.08% | 106,210 | 510.36K |
| 203 | IVVD | Invivyd, Inc. | 582.81M | 4.17% | 4,608,057 | 50.04M |
| 204 | PRTA | Prothena Corporation plc | 564.14M | 4.28% | 460,437 | 11.79M |
| 205 | EVMN | Evommune, Inc. | 562.75M | - | 50,201 | 3.00M |
| 206 | CGEM | Cullinan Therapeutics, Inc. | 559.45M | 8.60% | 2,115,086 | - |
| 207 | IVA | Inventiva S.A. | 554.46M | 10.82% | 164,875 | 19.93M |
| 208 | JBIO | Jade Biosciences, Inc. | 552.05M | 4.53% | 286,581 | - |
| 209 | NAGE | Niagen Bioscience, Inc. | 551.01M | 2.53% | 842,522 | 124.71M |
| 210 | KROS | Keros Therapeutics, Inc. | 529.80M | 3.39% | 1,438,461 | 246.72M |
| 211 | ALT | Altimmune, Inc. | 501.89M | 7.61% | 3,478,643 | 20.00K |
| 212 | ADCT | ADC Therapeutics SA | 497.99M | 0.75% | 1,532,798 | 75.21M |
| 213 | NBP | NovaBridge Biosciences | 487.58M | 0.95% | 288,170 | - |
| 214 | LXRX | Lexicon Pharmaceuticals, Inc. | 486.95M | 1.52% | 1,859,339 | 70.86M |
| 215 | ZVRA | Zevra Therapeutics, Inc. | 484.16M | -4.97% | 3,337,921 | 84.39M |
| 216 | DSGN | Design Therapeutics, Inc. | 475.65M | 6.10% | 279,938 | - |
| 217 | IMRX | Immuneering Corporation | 471.36M | 4.43% | 1,044,095 | - |
| 218 | DNA | Ginkgo Bioworks Holdings, Inc. | 464.35M | 4.48% | 1,046,847 | 180.61M |
| 219 | DBVT | DBV Technologies S.A. | 464.35M | -0.94% | 80,874 | 5.50M |
| 220 | DRUG | Bright Minds Biosciences Inc. | 454.80M | 2.00% | 255,823 | - |
| 221 | ENGN | enGene Holdings Inc. | 449.46M | 5.45% | 717,679 | - |
| 222 | BNTC | Benitec Biopharma Inc. | 449.01M | 0.91% | 117,672 | - |
| 223 | ABSI | Absci Corporation | 440.59M | 5.78% | 4,047,616 | 2.82M |
| 224 | BCYC | Bicycle Therapeutics plc | 438.41M | 2.43% | 284,312 | 28.34M |
| 225 | LCTX | Lineage Cell Therapeutics, Inc. | 421.65M | 4.19% | 1,061,935 | 10.82M |
| 226 | ANRO | Alto Neuroscience, Inc. | 411.63M | -6.36% | 337,927 | - |
| 227 | LYEL | Lyell Immunopharma, Inc. | 405.90M | 9.75% | 77,792 | 41.00K |
| 228 | DMAC | DiaMedica Therapeutics Inc. | 397.35M | 5.68% | 781,169 | - |
| 229 | XOMA | XOMA Royalty Corporation | 393.16M | -0.25% | 44,947 | 47.11M |
| 230 | NMRA | Neumora Therapeutics, Inc. | 389.32M | -1.27% | 679,906 | - |
| 231 | LBRX | LB Pharmaceuticals Inc | 387.84M | -2.91% | 46,184 | - |
| 232 | PRTC | PureTech Health plc | 382.75M | -2.27% | 2,849 | 6.39M |
| 233 | PEPG | PepGen Inc. | 382.24M | 9.23% | 1,838,338 | - |
| 234 | ENTA | Enanta Pharmaceuticals, Inc. | 367.42M | 4.95% | 273,607 | 65.32M |
| 235 | VTVT | vTv Therapeutics Inc. | 366.81M | -5.30% | 10,097 | 17.00K |
| 236 | SLDB | Solid Biosciences Inc. | 366.18M | 5.38% | 1,290,037 | - |
| 237 | TRDA | Entrada Therapeutics, Inc. | 362.56M | 10.25% | 352,423 | 61.52M |
| 238 | OCGN | Ocugen, Inc. | 362.29M | 4.50% | 2,364,831 | 5.37M |
| 239 | TECX | Tectonic Therapeutic, Inc. | 358.98M | 6.20% | 401,942 | - |
| 240 | AURA | Aura Biosciences, Inc. | 345.46M | 1.68% | 159,798 | - |
| 241 | GALT | Galectin Therapeutics Inc. | 344.93M | -6.79% | 408,809 | - |
| 242 | CLLS | Cellectis S.A. | 341.42M | -1.88% | 117,408 | 82.55M |
| 243 | TENX | Tenax Therapeutics, Inc. | 330.65M | 5.78% | 237,884 | - |
| 244 | FBRX | Forte Biosciences, Inc. | 328.37M | -10.00% | 346,555 | - |
| 245 | XFOR | X4 Pharmaceuticals, Inc. | 327.45M | 1.22% | 249,912 | 33.98M |
| 246 | AUTL | Autolus Therapeutics plc | 327.36M | - | 1,690,859 | 51.13M |
| 247 | DRTS | Alpha Tau Medical Ltd. | 324.87M | 10.09% | 60,920 | - |
| 248 | AVTX | Avalo Therapeutics, Inc. | 323.33M | 0.51% | 164,530 | 192.00K |
| 249 | CTNM | Contineum Therapeutics, Inc. | 319.40M | -10.43% | 687,574 | - |
| 250 | EPRX | Eupraxia Pharmaceuticals Inc. | 318.64M | - | 26,038 | - |
| 251 | PALI | Palisade Bio, Inc. | 317.38M | -8.97% | 3,907,972 | - |
| 252 | RCKT | Rocket Pharmaceuticals, Inc. | 317.09M | 3.17% | 1,406,911 | - |
| 253 | RLMD | Relmada Therapeutics, Inc. | 313.13M | -1.16% | 1,176,445 | - |
| 254 | NGNE | Neurogene Inc. | 310.73M | -1.67% | 188,546 | 925.00K |
| 255 | KYTX | Kyverna Therapeutics, Inc. | 310.51M | -4.70% | 451,798 | - |
| 256 | LRMR | Larimar Therapeutics, Inc. | 304.70M | 5.64% | 1,149,467 | - |
| 257 | PYXS | Pyxis Oncology, Inc. | 298.87M | 5.96% | 726,885 | 2.82M |
| 258 | ALDX | Aldeyra Therapeutics, Inc. | 298.41M | 4.86% | 647,484 | - |
| 259 | SLN | Silence Therapeutics plc | 297.57M | -0.79% | 181,360 | 25.83M |
| 260 | ACIU | AC Immune SA | 296.83M | 3.09% | 86,151 | 5.48M |
| 261 | MREO | Mereo BioPharma Group plc | 286.44M | 0.56% | 989,744 | 500.00K |
| 262 | VNDA | Vanda Pharmaceuticals Inc. | 283.66M | -0.83% | 755,906 | 212.07M |
| 263 | NAUT | Nautilus Biotechnology, Inc. | 282.92M | 5.91% | 252,804 | - |
| 264 | TARA | Protara Therapeutics, Inc. | 280.14M | 12.73% | 1,674,213 | - |
| 265 | AVXL | Anavex Life Sciences Corp. | 280.01M | 2.84% | 2,798,054 | - |
| 266 | CYBN | Cybin Inc. | 278.96M | -4.44% | 621,765 | - |
| 267 | ALLO | Allogene Therapeutics, Inc. | 276.42M | -0.81% | 1,588,413 | 22.00K |
| 268 | ACRS | Aclaris Therapeutics, Inc. | 271.95M | 4.15% | 902,575 | 15.74M |
| 269 | FENC | Fennec Pharmaceuticals Inc. | 269.13M | 0.51% | 262,705 | 38.79M |
| 270 | CAPR | Capricor Therapeutics, Inc. | 262.88M | 1.05% | 1,874,713 | 11.13M |
| 271 | FHTX | Foghorn Therapeutics Inc. | 261.27M | 0.65% | 217,110 | 24.52M |
| 272 | OBIO | Orchestra BioMed Holdings, Inc. | 255.79M | 2.93% | 225,601 | 2.82M |
| 273 | ARMP | Armata Pharmaceuticals, Inc. | 255.40M | -1.68% | 56,420 | 5.05M |
| 274 | CBIO | Crescent Biopharma, Inc. | 255.32M | -0.15% | 24,799 | - |
| 275 | OABI | OmniAb, Inc. | 254.80M | 5.99% | 445,648 | 21.09M |
| 276 | CADL | Candel Therapeutics, Inc. | 249.79M | 2.94% | 745,146 | - |
| 277 | PBYI | Puma Biotechnology, Inc. | 246.41M | 1.03% | 421,941 | 212.00M |
| 278 | IMMP | Immutep Limited | 246.38M | 1.78% | 111,112 | 3.31M |
| 279 | MIST | Milestone Pharmaceuticals Inc. | 243.80M | 3.90% | 2,896,663 | - |
| 280 | ABEO | Abeona Therapeutics Inc. | 242.78M | 6.16% | 1,814,692 | 400.00K |
| 281 | CCCC | C4 Therapeutics, Inc. | 236.47M | 2.52% | 1,181,973 | 30.11M |
| 282 | EDIT | Editas Medicine, Inc. | 236.24M | -2.02% | 1,977,848 | 46.38M |
| 283 | ZURA | Zura Bio Limited | 236.03M | -1.09% | 415,149 | - |
| 284 | VYGR | Voyager Therapeutics, Inc. | 232.41M | 2.20% | 280,111 | 31.32M |
| 285 | AVIR | Atea Pharmaceuticals, Inc. | 232.04M | -1.00% | 560,056 | - |
| 286 | HUMA | Humacyte, Inc. | 228.47M | 8.93% | 6,038,076 | 1.57M |
| 287 | MDWD | MediWound Ltd. | 218.31M | 0.99% | 130,356 | 20.93M |
| 288 | SLS | SELLAS Life Sciences Group, Inc. | 217.94M | 4.79% | 2,968,949 | - |
| 289 | PRQR | ProQR Therapeutics N.V. | 217.01M | - | 175,345 | 18.86M |
| 290 | SGMT | Sagimet Biosciences Inc. | 216.92M | -8.25% | 1,506,962 | - |
| 291 | BDTX | Black Diamond Therapeutics, Inc. | 216.50M | -0.26% | 1,181,178 | 70.00M |
| 292 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 210.81M | 2.74% | 368,813 | - |
| 293 | ACHV | Achieve Life Sciences, Inc. | 210.81M | 2.06% | 431,825 | - |
| 294 | TLSA | Tiziana Life Sciences Ltd | 206.75M | 7.74% | 328,634 | - |
| 295 | TNYA | Tenaya Therapeutics, Inc. | 204.80M | 6.03% | 2,355,224 | - |
| 296 | AARD | Aardvark Therapeutics, Inc. | 204.02M | -0.64% | 254,156 | - |
| 297 | CABA | Cabaletta Bio, Inc. | 200.23M | -3.26% | 3,144,956 | - |
| 298 | RANI | Rani Therapeutics Holdings, Inc. | 198.06M | 5.84% | 2,671,183 | 1.20M |
| 299 | HRTX | Heron Therapeutics, Inc. | 194.36M | 0.47% | 2,108,959 | 155.10M |
| 300 | GUTS | Fractyl Health, Inc. | 191.86M | 8.53% | 2,667,029 | 3.00K |
| 301 | TNXP | Tonix Pharmaceuticals Holding Corp. | 189.60M | 2.94% | 661,537 | 10.30M |
| 302 | RNAC | Cartesian Therapeutics, Inc. | 188.27M | 1.26% | 127,386 | 1.09M |
| 303 | SABS | SAB Biotherapeutics, Inc. | 188.05M | 3.95% | 137,602 | 114.70K |
| 304 | GNLX | Genelux Corporation | 186.59M | 6.90% | 125,567 | 8.00K |
| 305 | VTGN | Vistagen Therapeutics, Inc. | 181.28M | 3.15% | 527,709 | 721.00K |
| 306 | ARCT | Arcturus Therapeutics Holdings Inc. | 177.86M | 6.10% | 1,442,560 | 97.60M |
| 307 | IPHA | Innate Pharma S.A. | 171.70M | - | 22,677 | 14.84M |
| 308 | CNTB | Connect Biopharma Holdings Limited | 169.95M | -3.49% | 546,467 | 762.00K |
| 309 | CRBU | Caribou Biosciences, Inc. | 163.57M | - | 1,186,526 | 9.30M |
| 310 | ETHZ | ETHZilla Corporation | 160.50M | 0.39% | 903,249 | 4.11M |
| 311 | MCRB | Seres Therapeutics, Inc. | 160.21M | -18.39% | 471,984 | 351.00K |
| 312 | NVCT | Nuvectis Pharma, Inc. | 155.74M | 3.40% | 78,526 | - |
| 313 | VOR | Vor Biopharma Inc. | 152.06M | 8.60% | 735,693 | - |
| 314 | ELTX | Elicio Therapeutics, Inc. | 147.66M | 5.76% | 60,152 | - |
| 315 | ACTU | Actuate Therapeutics, Inc. | 146.67M | 3.61% | 75,533 | - |
| 316 | IMMX | Immix Biopharma, Inc. | 145.39M | 7.71% | 382,483 | - |
| 317 | AGEN | Agenus Inc. | 143.52M | -1.63% | 374,401 | 106.83M |
| 318 | CGEN | Compugen Ltd. | 143.11M | 0.66% | 194,312 | 6.90M |
| 319 | ANIX | Anixa Biosciences, Inc. | 142.86M | -1.36% | 144,956 | - |
| 320 | MOLN | Molecular Partners AG | 142.80M | 1.94% | 2,156 | 856.30K |
| 321 | SGMO | Sangamo Therapeutics, Inc. | 142.47M | 9.97% | 63,683,809 | 32.88M |
| 322 | PLX | Protalix BioTherapeutics, Inc. | 140.74M | 0.57% | 682,403 | 61.84M |
| 323 | CHRS | Coherus Oncology, Inc. | 140.21M | 5.45% | 881,133 | 277.73M |
| 324 | CDXS | Codexis, Inc. | 139.10M | -1.91% | 1,239,602 | 52.93M |
| 325 | SAVA | Cassava Sciences, Inc. | 138.64M | 9.13% | 1,904,606 | - |
| 326 | PRLD | Prelude Therapeutics Incorporated | 137.60M | 4.37% | 429,849 | 10.50M |
| 327 | CRDF | Cardiff Oncology, Inc. | 137.08M | 3.83% | 1,232,350 | 501.00K |
| 328 | MRSN | Mersana Therapeutics, Inc. | 136.47M | -0.76% | 117,229 | 33.18M |
| 329 | CAMP | Camp4 Therapeutics Corporation | 135.96M | -17.38% | 201,176 | 3.80M |
| 330 | ALEC | Alector, Inc. | 135.35M | 3.33% | 1,064,571 | 69.05M |
| 331 | IRD | Opus Genetics, Inc. | 131.72M | -1.04% | 162,686 | 14.63M |
| 332 | KLRS | Kalaris Therapeutics, Inc. | 131.10M | 1.59% | 198,276 | - |
| 333 | SPRO | Spero Therapeutics, Inc. | 130.14M | 2.21% | 171,815 | 40.55M |
| 334 | EXOZ | eXoZymes, Inc. | 128.70M | -3.49% | 1,020 | -700.00 |
| 335 | STTK | Shattuck Labs, Inc. | 128.46M | 5.18% | 93,594 | 1.00M |
| 336 | NKTX | Nkarta, Inc. | 127.85M | 4.05% | 541,195 | - |
| 337 | COYA | Coya Therapeutics, Inc. | 125.13M | - | 127,002 | 3.99M |
| 338 | ACOG | Alpha Cognition Inc. | 125.02M | -1.11% | 46,657 | 7.43M |
| 339 | CGTX | Cognition Therapeutics, Inc. | 122.70M | 4.51% | 918,117 | - |
| 340 | INO | Inovio Pharmaceuticals, Inc. | 120.92M | 1.73% | 754,410 | 182.34K |
| 341 | DTIL | Precision BioSciences, Inc. | 120.36M | 0.40% | 159,526 | 698.00K |
| 342 | QNCX | Quince Therapeutics, Inc. | 119.16M | 4.90% | 517,377 | - |
| 343 | FATE | Fate Therapeutics, Inc. | 118.81M | 3.00% | 1,071,020 | 7.14M |
| 344 | CNTX | Context Therapeutics Inc. | 116.18M | -4.39% | 701,969 | - |
| 345 | UNCY | Unicycive Therapeutics, Inc. | 116.05M | 2.47% | 177,564 | - |
| 346 | CLYM | Climb Bio, Inc. | 115.91M | -1.73% | 278,476 | - |
| 347 | ENTX | Entera Bio Ltd. | 115.53M | -1.94% | 66,971 | 124.00K |
| 348 | NTHI | NeOnc Technologies Holdings, Inc. | 114.12M | -0.88% | 85,289 | 59.99K |
| 349 | SRZN | Surrozen, Inc. | 113.14M | -3.93% | 49,498 | 3.60M |
| 350 | GLSI | Greenwich LifeSciences, Inc. | 112.91M | -0.12% | 80,655 | - |
| 351 | SPRB | Spruce Biosciences, Inc. | 112.39M | 2.33% | 305,213 | 697.00K |
| 352 | IKT | Inhibikase Therapeutics, Inc. | 112.01M | -2.61% | 3,182,018 | 1.00 |
| 353 | SEER | Seer, Inc. | 109.90M | 1.55% | 166,358 | 16.38M |
| 354 | NBY | NovaBay Pharmaceuticals, Inc. | 108.60M | -12.95% | 156,775 | 10.30M |
| 355 | ELDN | Eledon Pharmaceuticals, Inc. | 108.21M | 3.60% | 1,544,583 | - |
| 356 | ONCY | Oncolytics Biotech Inc. | 106.15M | 0.86% | 535,654 | - |
| 357 | ORMP | Oramed Pharmaceuticals Inc. | 102.69M | 6.61% | 763,445 | 2.00M |
| 358 | SLGL | Sol-Gel Technologies Ltd. | 102.10M | 2.52% | 3,795 | 18.97M |
| 359 | ATOS | Atossa Therapeutics, Inc. | 100.78M | 3.75% | 594,929 | - |
| 360 | ANVS | Annovis Bio, Inc. | 100.45M | -2.32% | 1,969,291 | - |
| 361 | KPTI | Karyopharm Therapeutics Inc. | 99.75M | 1.56% | 61,567 | 142.53M |
| 362 | OVID | Ovid Therapeutics Inc. | 99.70M | 14.75% | 1,302,267 | 6.61M |
| 363 | WHWK | Whitehawk Therapeutics, Inc. | 99.44M | 6.03% | 98,674 | 14.38M |
| 364 | ATRA | Atara Biotherapeutics, Inc. | 98.64M | 3.48% | 47,493 | 151.93M |
| 365 | ACET | Adicet Bio, Inc. | 97.07M | 3.95% | 981,860 | - |
| 366 | ZNTL | Zentalis Pharmaceuticals, Inc. | 96.82M | 3.08% | 388,898 | 26.87M |
| 367 | ANEB | Anebulo Pharmaceuticals, Inc. | 96.75M | 2.84% | 2,495 | - |
| 368 | VANI | Vivani Medical, Inc. | 96.30M | -2.22% | 164,171 | - |
| 369 | TTRX | Turn Therapeutics Inc. | 96.29M | 20.66% | 146,544 | - |
| 370 | GANX | Gain Therapeutics, Inc. | 96.02M | -6.67% | 971,257 | - |
| 371 | PLRX | Pliant Therapeutics, Inc. | 95.25M | -0.64% | 318,299 | - |
| 372 | ABOS | Acumen Pharmaceuticals, Inc. | 95.10M | 0.64% | 82,604 | - |
| 373 | CSBR | Champions Oncology, Inc. | 93.35M | 1.65% | 13,535 | 56.88M |
| 374 | ADVM | Adverum Biotechnologies, Inc. | 91.40M | -1.19% | 206,446 | 1.00M |
| 375 | RPTX | Repare Therapeutics Inc. | 90.70M | 0.48% | 1,177,484 | 11.87M |
| 376 | COEP | Coeptis Therapeutics Holdings, Inc. | 89.77M | 3.07% | 52,506 | 501.00K |
| 377 | TVGN | Tevogen Bio Holdings Inc. | 89.59M | 9.10% | 748,083 | - |
| 378 | HURA | TuHURA Biosciences, Inc. | 89.19M | 9.78% | 160,066 | - |
| 379 | TIL | Instil Bio, Inc. | 89.12M | 9.77% | 130,077 | - |
| 380 | MGNX | MacroGenics, Inc. | 88.25M | 1.82% | 731,823 | 127.63M |
| 381 | VXRT | Vaxart, Inc. | 87.34M | -3.29% | - | 148.20M |
| 382 | THAR | Tharimmune, Inc. | 85.86M | 8.89% | 254,861 | - |
| 383 | ADAG | Adagene Inc. | 84.84M | 1.69% | 3,291,581 | 103.20K |
| 384 | OTLK | Outlook Therapeutics, Inc. | 83.51M | - | 2,165,973 | 1.51M |
| 385 | IMUX | Immunic, Inc. | 82.56M | -0.16% | 608,297 | - |
| 386 | CRVO | CervoMed Inc. | 82.16M | -1.44% | 101,726 | 6.16M |
| 387 | IFRX | InflaRx N.V. | 79.94M | 2.61% | 928,637 | 73.73K |
| 388 | OKYO | OKYO Pharma Limited | 79.73M | 10.99% | 309,522 | - |
| 389 | PTHS | Pelthos Therapeutics Inc. | 77.77M | -12.41% | 19,138 | 7.41M |
| 390 | ALXO | ALX Oncology Holdings Inc. | 77.53M | 5.15% | 178,057 | - |
| 391 | BYSI | BeyondSpring Inc. | 77.24M | 10.06% | 26,234 | 1.88M |
| 392 | HYFT | MindWalk Holdings Corp. | 77.08M | -5.65% | 327,619 | 18.21M |
| 393 | FBIO | Fortress Biotech, Inc. | 77.06M | 2.37% | 179,568 | 62.30M |
| 394 | ARTV | Artiva Biotherapeutics, Inc. | 76.83M | -1.26% | 83,694 | 251.00K |
| 395 | IMA | ImageneBio, Inc. | 75.73M | -0.56% | 61,688 | 800.00K |
| 396 | PSTV | Plus Therapeutics, Inc. | 73.21M | 9.07% | 4,434,492 | 5.26M |
| 397 | ACRV | Acrivon Therapeutics, Inc. | 72.58M | 1.77% | 225,287 | - |
| 398 | STRO | Sutro Biopharma, Inc. | 71.79M | -0.39% | 397,012 | 105.65M |
| 399 | PMVP | PMV Pharmaceuticals, Inc. | 70.24M | 0.76% | 167,457 | - |
| 400 | MNOV | MediciNova, Inc. | 70.14M | 0.70% | 57,049 | 257.92K |
| 401 | XBIT | XBiotech Inc. | 69.51M | 2.70% | 61,269 | - |
| 402 | BMEA | Biomea Fusion, Inc. | 69.43M | -1.80% | 2,546,390 | - |
| 403 | CBUS | Cibus, Inc. | 68.13M | -0.40% | 79,209 | 3.79M |
| 404 | ATYR | aTyr Pharma, Inc. | 65.11M | 2.01% | 2,839,909 | 190.00K |
| 405 | ABVC | ABVC BioPharma, Inc. | 63.40M | 1.13% | 49,380 | 797.92K |
| 406 | ATHE | Alterity Therapeutics Limited | 63.31M | -0.28% | 1,949 | 3.57M |
| 407 | LITS | Lite Strategy, Inc. | 62.54M | - | 664,897 | - |
| 408 | PYPD | PolyPid Ltd. | 59.89M | -0.83% | 54,366 | - |
| 409 | KRRO | Korro Bio, Inc. | 59.14M | 4.84% | 546,759 | 7.37M |
| 410 | RVPH | Reviva Pharmaceuticals Holdings, Inc. | 58.94M | 6.73% | 3,879,586 | - |
| 411 | EQ | Equillium, Inc. | 58.46M | -4.95% | 317,438 | 4.39M |
| 412 | NTRB | Nutriband Inc. | 57.44M | -5.16% | 30,185 | 2.58M |
| 413 | ESLA | Estrella Immunopharma, Inc. | 57.40M | -6.17% | 210,788 | - |
| 414 | OSTX | OS Therapies Incorporated | 57.34M | 5.56% | 144,017 | - |
| 415 | MGX | Metagenomi, Inc. | 56.70M | - | 510,378 | 30.91M |
| 416 | ALGS | Aligos Therapeutics, Inc. | 56.67M | 11.50% | 97,256 | 2.65M |
| 417 | TCRX | TScan Therapeutics, Inc. | 54.64M | -2.27% | 644,654 | 8.42M |
| 418 | IOBT | IO Biotech, Inc. | 52.38M | 7.62% | 716,874 | - |
| 419 | BCAB | BioAtla, Inc. | 51.10M | -25.07% | 4,168,317 | 11.00M |
| 420 | SNTI | Senti Biosciences, Inc. | 51.00M | 7.18% | 228,243 | - |
| 421 | NRXP | NRx Pharmaceuticals, Inc. | 50.63M | 4.93% | 438,295 | 242.00K |
| 422 | CVM | CEL-SCI Corporation | 50.04M | 2.29% | 74,777 | - |
| 423 | ANL | Adlai Nortye Ltd. | 49.82M | -5.59% | 3,427 | 1.94M |
| 424 | CELU | Celularity Inc. | 49.58M | 2.34% | 29,683 | 40.58M |
| 425 | INKT | MiNK Therapeutics, Inc. | 49.57M | -2.94% | 18,825 | - |
| 426 | JSPR | Jasper Therapeutics, Inc. | 47.85M | -2.84% | 300,226 | - |
| 427 | IBO | Impact BioMedical Inc. | 47.60M | 1.11% | 14,805 | 25.00K |
| 428 | CALC | CalciMedica, Inc. | 47.41M | 4.11% | 17,357 | - |
| 429 | CUE | Cue Biopharma, Inc. | 46.85M | 10.02% | 275,030 | 7.10M |
| 430 | LVTX | LAVA Therapeutics N.V. | 45.77M | - | - | 4.99M |
| 431 | KZR | Kezar Life Sciences, Inc. | 45.77M | 1.46% | 32,250 | - |
| 432 | GRCE | Grace Therapeutics, Inc. | 45.07M | 1.59% | 20,983 | - |
| 433 | TELO | Telomir Pharmaceuticals, Inc. | 44.01M | -7.91% | 6,092,383 | - |
| 434 | EVAX | Evaxion A/S | 43.01M | -3.00% | 115,446 | 7.65M |
| 435 | IPSC | Century Therapeutics, Inc. | 42.78M | -0.14% | 560,144 | 113.34M |
| 436 | SER | Serina Therapeutics, Inc. | 42.55M | 6.12% | 7,463 | 116.00K |
| 437 | HOWL | Werewolf Therapeutics, Inc. | 42.39M | 2.16% | 789,191 | 1.14M |
| 438 | ICCC | ImmuCell Corporation | 42.33M | 1.74% | 8,579 | 27.77M |
| 439 | BTAI | BioXcel Therapeutics, Inc. | 41.77M | 6.70% | 361,673 | 752.00K |
| 440 | ATNM | Actinium Pharmaceuticals, Inc. | 41.49M | 3.10% | 118,175 | 90.00K |
| 441 | PDSB | PDS Biotechnology Corporation | 41.34M | -0.09% | 423,056 | - |
| 442 | JUNS | Jupiter Neurosciences, Inc. | 41.10M | -4.07% | 64,822 | - |
| 443 | INMB | INmune Bio, Inc. | 40.14M | 1.34% | 296,714 | 50.00K |
| 444 | VRCA | Verrica Pharmaceuticals Inc. | 39.95M | 4.73% | 53,249 | 30.83M |
| 445 | XLO | Xilio Therapeutics, Inc. | 39.53M | 0.40% | 232,415 | 31.80M |
| 446 | GNTA | Genenta Science S.p.A. | 39.37M | -3.45% | 397,605 | - |
| 447 | RNTX | Rein Therapeutics Inc. | 38.64M | 6.52% | 238,499 | - |
| 448 | RADX | Radiopharm Theranostics Limited | 38.49M | 1.34% | 5,841 | 8.20M |
| 449 | SKYE | Skye Bioscience, Inc. | 37.35M | -6.80% | 326,664 | - |
| 450 | APLT | Applied Therapeutics, Inc. | 37.33M | -7.84% | 9,340,825 | 1.00M |
| 451 | TVRD | Tvardi Therapeutics, Inc. | 36.77M | 2.62% | 113,446 | - |
| 452 | MURA | Mural Oncology plc | 36.21M | -0.48% | 73,063 | - |
| 453 | VERU | Veru Inc. | 35.63M | -0.45% | 162,404 | 16.89M |
| 454 | NXTC | NextCure, Inc. | 35.61M | 14.12% | 42,370 | - |
| 455 | PLUR | Pluri Inc. | 35.16M | -2.56% | 7,003 | 1.33M |
| 456 | OKUR | OnKure Therapeutics, Inc. | 34.95M | -1.53% | 50,469 | - |
| 457 | FGEN | FibroGen, Inc. | 34.06M | 1.45% | 30,776 | 8.30M |
| 458 | GBIO | Generation Bio Co. | 33.78M | 0.08% | 89,123 | 15.27M |
| 459 | LTRN | Lantern Pharma Inc. | 33.78M | 0.67% | 85,253 | - |
| 460 | MAIA | MAIA Biotechnology, Inc. | 33.75M | 4.65% | 151,040 | - |
| 461 | KLTO | Klotho Neurosciences, Inc. | 33.58M | 15.17% | 2,401,068 | - |
| 462 | DYAI | Dyadic International, Inc. | 33.29M | -0.55% | 175,248 | 3.34M |
| 463 | SONN | Sonnet BioTherapeutics Holdings, Inc. | 31.06M | 3.17% | 636,770 | 1.00M |
| 464 | APLM | Apollomics, Inc. | 31.03M | -1.97% | 13,961 | 198.00K |
| 465 | ANTX | AN2 Therapeutics, Inc. | 29.87M | 0.93% | 22,318 | - |
| 466 | IGC | IGC Pharma, Inc. | 29.25M | 0.86% | 224,941 | 1.11M |
| 467 | BRNS | Barinthus Biotherapeutics plc | 29.19M | 2.67% | 82,543 | 14.97M |
| 468 | RNXT | RenovoRx, Inc. | 29.16M | 2.22% | 181,167 | 928.00K |
| 469 | LNAI | Lunai Bioworks Inc. | 28.74M | -13.89% | 425,571 | - |
| 470 | HYPD | Hyperion DeFi, Inc. | 28.72M | -7.18% | 352,165 | 345.32K |
| 471 | CLGN | CollPlant Biotechnologies Ltd. | 28.23M | 3.74% | 12,269 | 2.40M |
| 472 | NRXS | NeurAxis, Inc. | 27.91M | 4.38% | 97,810 | 3.36M |
| 473 | NERV | Minerva Neurosciences, Inc. | 27.55M | -9.22% | 42,655 | - |
| 474 | NRSN | NeuroSense Therapeutics Ltd. | 27.55M | 2.80% | 244,039 | - |
| 475 | XCUR | Exicure, Inc. | 26.58M | -0.24% | 95,965 | 500.00K |
| 476 | RLYB | Rallybio Corporation | 26.50M | 2.82% | 207,846 | 674.00K |
| 477 | CASI | CASI Pharmaceuticals, Inc. | 25.69M | 5.04% | 22,294 | 26.85M |
| 478 | BOLD | Boundless Bio, Inc. | 25.29M | 1.80% | 181,376 | - |
| 479 | QTTB | Q32 Bio Inc. | 24.61M | 3.63% | 100,103 | - |
| 480 | PASG | Passage Bio, Inc. | 24.59M | 3.97% | 35,268 | - |
| 481 | LIXT | Lixte Biotechnology Holdings, Inc. | 24.59M | -0.69% | 67,670 | - |
| 482 | INTS | Intensity Therapeutics, Inc. | 24.52M | 7.45% | 1,277,944 | - |
| 483 | DARE | Daré Bioscience, Inc. | 24.01M | 3.07% | 87,831 | -57.13K |
| 484 | NEUP | Neuphoria Therapeutics Inc. | 23.98M | 5.94% | 65,147 | 15.65M |
| 485 | CING | Cingulate Inc. | 23.85M | 2.02% | 100,493 | - |
| 486 | IBIO | iBio, Inc. | 23.61M | 5.52% | 683,792 | 500.00K |
| 487 | LEXX | Lexaria Bioscience Corp. | 23.35M | -4.98% | 81,727 | 615.92K |
| 488 | QNTM | Quantum BioPharma Ltd. | 23.08M | -6.95% | 57,712 | - |
| 489 | NNVC | NanoViricides, Inc. | 22.86M | 2.42% | 197,869 | - |
| 490 | PMN | ProMIS Neurosciences, Inc. | 22.60M | 10.01% | 1,106,499 | - |
| 491 | PTN | Palatin Technologies, Inc. | 22.39M | 57.49% | 562,111 | 8.85M |
| 492 | GLTO | Galecto, Inc. | 22.26M | -3.34% | 117,257 | - |
| 493 | ENLV | Enlivex Therapeutics Ltd. | 21.79M | -1.72% | 220,129 | - |
| 494 | MBRX | Moleculin Biotech, Inc. | 21.75M | 1.35% | 1,060,904 | - |
| 495 | GDTC | CytoMed Therapeutics Limited | 21.70M | 4.44% | 22,892 | 573.19K |
| 496 | CVKD | Cadrenal Therapeutics, Inc. | 21.11M | -10.00% | 30,421 | - |
| 497 | CTXR | Citius Pharmaceuticals, Inc. | 21.06M | 15.15% | 1,180,868 | - |
| 498 | ITRM | Iterum Therapeutics plc | 20.39M | 4.38% | 842,390 | 390.00K |
| 499 | LIMN | Liminatus Pharma, Inc. | 19.45M | -31.54% | 1,859,349 | - |
| 500 | APVO | Aptevo Therapeutics Inc. | 19.04M | 4.63% | 948,598 | - |
| 501 | SYBX | Synlogic, Inc. | 18.84M | 0.63% | 11,041 | 8.00K |
| 502 | ABP | Abpro Holdings, Inc. | 18.78M | 10.52% | 36,984 | 183.00K |
| 503 | TRAW | Traws Pharma, Inc. | 18.46M | 7.94% | 164,176 | 2.85M |
| 504 | ATHA | Athira Pharma, Inc. | 18.16M | 1.43% | 28,374 | - |
| 505 | MRKR | Marker Therapeutics, Inc. | 17.67M | 6.62% | 268,881 | 4.69M |
| 506 | LPCN | Lipocine Inc. | 17.54M | 0.32% | 21,482 | 4.32M |
| 507 | FBLG | FibroBiologics, Inc. | 17.50M | 4.74% | 422,959 | - |
| 508 | LSTA | Lisata Therapeutics, Inc. | 17.29M | -1.51% | 28,224 | 1.07M |
| 509 | PULM | Pulmatrix, Inc. | 17.17M | 0.75% | 3,947 | 3.00K |
| 510 | HOTH | Hoth Therapeutics, Inc. | 16.83M | 5.34% | 252,272 | - |
| 511 | MTVA | MetaVia Inc. | 16.82M | 4.75% | 68,674 | - |
| 512 | AKTX | Akari Therapeutics, Plc | 16.22M | -1.86% | 85,440 | - |
| 513 | CANF | Can-Fite BioPharma Ltd. | 15.72M | -5.19% | 2,642,705 | 560.00K |
| 514 | TPST | Tempest Therapeutics, Inc. | 15.54M | -4.89% | 287,691 | - |
| 515 | ALLR | Allarity Therapeutics, Inc. | 15.40M | 6.78% | 236,810 | - |
| 516 | QNRX | Quoin Pharmaceuticals, Ltd. | 15.35M | -0.68% | 53,854 | - |
| 517 | KZIA | Kazia Therapeutics Limited | 15.32M | 11.63% | 275,424 | 1.20M |
| 518 | BLRX | BioLineRx Ltd. | 15.23M | -3.85% | 19,173 | 17.25M |
| 519 | CRIS | Curis, Inc. | 15.13M | 8.33% | 78,148 | 11.65M |
| 520 | NCEL | NewcelX Ltd. | 14.91M | 5.97% | 16,831 | - |
| 521 | NCNA | NuCana plc | 14.57M | -1.55% | 69,390 | - |
| 522 | BCDA | BioCardia, Inc. | 14.54M | 7.03% | 77,537 | 3.00K |
| 523 | DWTX | Dogwood Therapeutics, Inc. | 14.54M | 6.55% | 30,474 | - |
| 524 | OSRH | OSR Holdings, Inc. | 14.44M | 23.38% | 138,546,240 | -90.52K |
| 525 | PCSA | Processa Pharmaceuticals, Inc. | 14.33M | -7.16% | 1,023,741 | - |
| 526 | CLSD | Clearside Biomedical, Inc. | 14.24M | 4.21% | 26,440 | 3.33M |
| 527 | SNGX | Soligenix, Inc. | 14.22M | 11.02% | 235,990 | 2.34K |
| 528 | KAPA | Kairos Pharma, Ltd. | 14.00M | -2.07% | 146,220 | - |
| 529 | BCTX | BriaCell Therapeutics Corp. | 13.69M | 13.96% | 38,484 | - |
| 530 | CMMB | Chemomab Therapeutics Ltd. | 13.09M | 4.12% | 72,318 | - |
| 531 | LGVN | Longeveron Inc. | 12.80M | -0.56% | 487,824 | 1.44M |
| 532 | COCP | Cocrystal Pharma, Inc. | 12.42M | -2.04% | 80,017 | - |
| 533 | CLRB | Cellectar Biosciences, Inc. | 12.13M | 1.42% | 59,492 | - |
| 534 | PHIO | Phio Pharmaceuticals Corp. | 12.06M | -5.88% | 565,553 | - |
| 535 | EDSA | Edesa Biotech, Inc. | 11.93M | -2.02% | 19,129 | - |
| 536 | VYNE | VYNE Therapeutics Inc. | 11.72M | 1.03% | 252,494 | 524.00K |
| 537 | GOVX | GeoVax Labs, Inc. | 11.64M | -2.27% | 467,000 | 3.35M |
| 538 | IMRN | Immuron Limited | 11.27M | 3.70% | 36,580 | 4.78M |
| 539 | IMNN | Imunon, Inc. | 11.18M | -1.36% | 34,938 | - |
| 540 | ICU | SeaStar Medical Holding Corporation | 10.99M | -1.61% | 719,891 | 881.00K |
| 541 | PPCB | Propanc Biopharma, Inc. | 10.83M | -2.09% | 30,742 | - |
| 542 | SNSE | Sensei Biotherapeutics, Inc. | 10.73M | -3.30% | 17,737 | - |
| 543 | ERNA | Ernexa Therapeutics Inc. | 10.60M | 5.47% | 46,101 | 1,000.00 |
| 544 | APM | Aptorum Group Limited | 10.59M | -9.09% | 150,373 | - |
| 545 | EVGN | Evogene Ltd. | 10.41M | 4.63% | 46,114 | 8.02M |
| 546 | ADXN | Addex Therapeutics Ltd | 10.12M | -0.51% | 5,561 | 210.35K |
| 547 | CELZ | Creative Medical Technology Holdings, Inc. | 10.09M | - | 88,783 | 6.00K |
| 548 | CLDI | Calidi Biotherapeutics, Inc. | 10.03M | -0.72% | 125,614 | - |
| 549 | BIVI | BioVie Inc. | 9.76M | 1.97% | 66,221 | - |
| 550 | BRTX | BioRestorative Therapies, Inc. | 9.75M | -1.08% | 60,097 | 383.40K |
| 551 | AEON | AEON Biopharma, Inc. | 9.66M | 1.21% | 124,286 | - |
| 552 | BOLT | Bolt Biotherapeutics, Inc. | 9.10M | -1.25% | 10,180 | 5.20M |
| 553 | ACXP | Acurx Pharmaceuticals, Inc. | 9.07M | 11.25% | 58,039 | - |
| 554 | ENTO | Entero Therapeutics, Inc. | 8.81M | 5.22% | 91,740 | - |
| 555 | MBIO | Mustang Bio, Inc. | 8.61M | 2.61% | 92,994 | - |
| 556 | XTLB | XTL Biopharmaceuticals Ltd. | 8.39M | -2.75% | 56,797 | 451.00K |
| 557 | INAB | IN8bio, Inc. | 7.88M | 6.92% | 49,578 | - |
| 558 | GTBP | GT Biopharma, Inc. | 7.81M | 4.13% | 761,492 | - |
| 559 | PLRZ | Polyrizon Ltd. | 7.53M | 8.70% | 90,338 | - |
| 560 | ALZN | Alzamend Neuro, Inc. | 7.45M | -0.51% | 73,162 | - |
| 561 | PHGE | BiomX Inc. | 7.40M | -7.27% | 1,021,455 | - |
| 562 | APRE | Aprea Therapeutics, Inc. | 7.32M | 4.50% | 30,699 | 488.24K |
| 563 | TOVX | Theriva Biologics, Inc. | 7.29M | 0.79% | 1,851,281 | - |
| 564 | ADIL | Adial Pharmaceuticals, Inc. | 7.22M | 0.84% | 1,586,933 | - |
| 565 | RNAZ | TransCode Therapeutics, Inc. | 7.20M | 0.93% | 4,447 | - |
| 566 | TCRT | Alaunos Therapeutics, Inc. | 7.05M | -10.99% | 53,505 | 6.00K |
| 567 | KPRX | Kiora Pharmaceuticals, Inc. | 6.86M | 3.89% | 20,881 | 20.00K |
| 568 | GRI | GRI Bio, Inc. | 6.70M | 0.49% | 376,233 | - |
| 569 | PPBT | Purple Biotech Ltd | 6.66M | 0.46% | 183,314 | - |
| 570 | BGMS | Bio Green Med Solution, Inc. | 6.13M | 1.63% | 61,115 | 81.00K |
| 571 | LYRA | Lyra Therapeutics, Inc. | 5.72M | 2.88% | 38,986 | 600.00K |
| 572 | VIVS | VivoSim Labs, Inc. | 5.66M | - | 25,848 | 140.00K |
| 573 | CYCN | Cyclerion Therapeutics, Inc. | 5.63M | 4.23% | 42,863 | 2.86M |
| 574 | ENSC | Ensysce Biosciences, Inc. | 5.63M | -1.24% | 64,581 | 4.49M |
| 575 | XBIO | Xenetic Biosciences, Inc. | 5.54M | 4.76% | 41,320 | 2.86M |
| 576 | MTNB | Matinas BioPharma Holdings, Inc. | 5.29M | -1.79% | 10,687 | - |
| 577 | SILO | Silo Pharma, Inc. | 5.20M | 7.34% | 81,841 | 72.10K |
| 578 | REVB | Revelation Biosciences, Inc. | 5.06M | 0.49% | 60,105 | - |
| 579 | GNPX | Genprex, Inc. | 4.90M | -5.06% | 180,602 | - |
| 580 | ASBP | Aspire Biopharma Holdings, Inc. | 4.82M | -0.31% | 16,271,884 | 1.94K |
| 581 | CDIO | Cardio Diagnostics Holdings, Inc. | 4.71M | 4.06% | 14,484 | 15.78K |
| 582 | HCWB | HCW Biologics Inc. | 4.67M | 12.84% | 47,048 | 422.03K |
| 583 | GLMD | Galmed Pharmaceuticals Ltd. | 4.59M | 2.72% | 391,970 | - |
| 584 | JAGX | Jaguar Health, Inc. | 4.52M | -2.42% | 58,144 | 11.79M |
| 585 | PMCB | PharmaCyte Biotech, Inc. | 4.42M | 3.17% | 59,531 | - |
| 586 | KALA | KALA BIO, Inc. | 4.35M | -4.44% | 107,463 | - |
| 587 | AIXC | AIxCrypto Holdings, Inc. | 4.31M | -3.42% | 153,434 | - |
| 588 | SXTP | 60 Degrees Pharmaceuticals, Inc. | 4.27M | - | 15,313 | 1.36M |
| 589 | PTIX | Protagenic Therapeutics, Inc. | 3.98M | 2.97% | 56,058 | - |
| 590 | CNSP | CNS Pharmaceuticals, Inc. | 3.96M | 5.99% | 12,799 | - |
| 591 | SPRC | SciSparc Ltd. | 3.91M | 2.55% | 23,708 | 1.31M |
| 592 | OGEN | Oragenics, Inc. | 3.73M | -1.93% | 47,506 | - |
| 593 | SLRX | Salarius Pharmaceuticals, Inc. | 3.68M | 16.08% | 946,370 | - |
| 594 | ELAB | PMGC Holdings Inc. | 3.51M | -1.05% | 12,680 | -241.53K |
| 595 | ONCO | Onconetix, Inc. | 3.45M | -5.15% | 12,288 | 1.22M |
| 596 | ARTL | Artelo Biosciences, Inc. | 3.37M | -2.34% | 26,791 | - |
| 597 | INDP | Indaptus Therapeutics, Inc. | 3.24M | 5.71% | 36,915 | - |
| 598 | AZTR | Azitra, Inc. | 3.20M | -1.57% | 264,323 | 7.50K |
| 599 | XRTX | XORTX Therapeutics Inc. | 3.13M | 4.73% | 148,939 | - |
| 600 | ENVB | Enveric Biosciences, Inc. | 3.00M | -1.20% | 34,750 | - |
| 601 | PBM | Psyence Biomedical Ltd. | 2.79M | -13.37% | 631,500 | - |
| 602 | SCNI | Scinai Immunotherapeutics Ltd. | 2.77M | -4.50% | 31,142 | 1.15M |
| 603 | BDRX | Biodexa Pharmaceuticals Plc | 2.71M | 11.45% | 8,449 | 104.90K |
| 604 | CDT | CDT Equity Inc. | 2.69M | -0.60% | 36,301 | - |
| 605 | KTTA | Pasithea Therapeutics Corp. | 2.18M | -29.58% | 3,310,667 | - |
| 606 | MLEC | Moolec Science SA | 1.81M | -4.38% | 51,087 | 7.83M |
| 607 | DRMA | Dermata Therapeutics, Inc. | 1.77M | 4.00% | 24,021 | - |
| 608 | VRAX | Virax Biolabs Group Limited | 1.62M | -6.92% | 119,765 | 6.33K |
| 609 | SLXN | Silexion Therapeutics Corp | 1.24M | -5.96% | 62,559 | - |
| 610 | CMND | Clearmind Medicine Inc. | 1.00M | -7.90% | 4,396,015 | - |
| 611 | ADTX | Aditxt, Inc. | 122.87K | -2.79% | 69,332 | 5.95K |